Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3306584 | 0.83 | SMN1; SMN2 (0.54) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 | |
| SCHEMBL464374 | 0.81 | CA12 (0.54) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 | |
| SCHEMBL27708944 | 0.80 | SMN1; SMN2 (0.56) | SMN1; SMN2ABCB1KDM4EALDH1A1CA12 | |
| SCHEMBL29740292 | 0.80 | CA1 (0.62) | SMN1; SMN2KDM4EALDH1A1CA12CA1 | |
| SCHEMBL400747 | 0.79 | IDO1 (0.50) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 | |
| Ammonia Solution, Strong SCHEMBL7313508 | 0.79 | CA12 (0.53) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 | |
| SCHEMBL216572 | 0.79 | SMN1; SMN2 (0.50) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 | |
| SCHEMBL17420764 | 0.79 | SMN1; SMN2 (0.50) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 | |
| SCHEMBL95872 | 0.79 | CA12 (0.53) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 | |
| SCHEMBL4369269 | 0.79 | ABCB1 (0.57) | SMN1; SMN2ABCB1KDM4EALDH1A1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4015592-B1 | CURABLE CONDENSATION COMPOUNDS ON THE BASIS OF ALKOXY-FUNCTIONAL POLYSILOXANES | EVONIK OPERATIONS GMBH (DE) | 2026-03-18 | — | — | EP | claimed |
| US-12460081-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2025-11-04 | — | — | US | claimed |
| US-12152109-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2024-11-26 | — | — | US | claimed |
| EP-4186954-A1 | CURABLE CONDENSATION COMPOUNDS BASED ON ALKOXY-FUNCTIONAL POLYSILOXANES | Evonik Operations GmbH (DE) | 2023-05-31 | — | — | EP | claimed |
| CN-116162247-A | Curable condensation compounds based on alkoxy-functional polysiloxanes | 赢创运营有限公司 | 2023-05-26 | — | — | CN | claimed |
| US-20230159756-A1 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2023-05-25 | — | — | US | claimed |
| CN-114621445-A | Curable condensation compounds based on alkoxy-functional polysiloxanes | 赢创运营有限公司 | 2022-06-14 | — | — | CN | claimed |
| US-20220177652-A1 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2022-06-09 | — | — | US | claimed |
| CN-110218382-B | Antenna housing material | 西安安聚德纳米科技有限公司 | 2022-03-11 | — | — | CN | claimed |
| US-12460081-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2025-11-04 | — | — | US | disclosed |
| US-12152109-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2024-11-26 | — | — | US | disclosed |
| US-11992538-B2 | Polymerizable dental composition based on condensed silanes | VOCO GMBH (DE) | 2024-05-28 | — | — | US | disclosed |
| WO-2024096021-A1 | HYDROPHOBIC LOW-LOSS-TANGENT SILICA SOL AND PRODUCTION METHOD THEREFOR | 日産化学株式会社 | 2024-05-10 | — | — | WO | disclosed |
| EP-3036296-B1 | COATING COMPOUNDS | EVONIK OPERATIONS GMBH (DE) | 2023-07-12 | — | — | EP | disclosed |
| WO-2003040200-A1 | HIGH REFRACTIVE INDEX AROMATIC-BASED PREPOLYMERS | BAUSCH & LOMB INCORPORATED (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003040193-A2 | METHOD FOR POLYMERIZING LENSES | BAUSCH & LOMB INCORPORATED (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003040214-A1 | HIGH REFRACTIVE INDEX AROMATIC-BASED PREPOLYMER PRECURSORS | BAUSCH & LOMB INCORPORATED (US) | 2003-05-15 | — | — | WO | disclosed |
| US-5378788-A | Process for preparation of linear organo-polysiloxane having hydroxyl group at its molecular ends | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1995-01-03 | — | — | US | disclosed |
| US-4717770-A | CYCLOHEXANONE OXIME, ZEOLITES, SURFACE TREATMENT WITH ORGANOSILICON OR ORGANOGERMANIUM COMPOUNDS | SUMITOMO CHEMICAL CO., LTD. (JP) | 1988-01-05 | — | — | US | disclosed |
| EP-0236092-A2 | Process for producing e-caprolactam | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992538-B2 | Polymerizable dental composition based on condensed silanes | NCAPH, RCC1, NCAPD2 | SMN1; SMN2 3310/4885ABCB1 4525/4885KDM4E 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.